Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference

About this update from Integra Lifesciences Holdings Corporation

PRINCETON, N.J. , May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET . A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations . About Integra LifeSciences At Integra LifeSciences , we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands that include Acclarent®, AmnioExcel®, Aurora®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, DuraSorb®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, NeuraWrap™, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit www.integralife.com . Investor Relations: Chris Ward (609) 772-7736 [email protected] Media Contact: Laurene Isip (609) 208-8121 [email protected] Integra LifeSciences Holdings Corporation Source: Integra LifeSciences Holdings Corporation

View stock analysis, news, and events for Integra Lifesciences Holdings Corporation